Maze Therapeutics stock hugs flat line following $140M IPO
Maze Therapeutics (NASDAQ:MAZE) shares were trading largely flat following a $140M initial public offering. Shares of the kidney disease drug developer opened at $16 per share after being priced at ...
The Daily Progress2h
Will Trump's deportations hit Virginia-based Smithfield Foods?
Smithfield Foods' CEO says he is watching Trump’s immigration policies closely, but he hasn’t seen any ICE raids at any of the company’s 41 plants yet.
Biotech firm Maze Therapeutics raises $140 million in US IPO
Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that will make the kidney disease drug developer the first U.S. biotech ...
Food Processing19h
Smithfield Foods Goes Public at a Muted $20 per Share
Smithfield Foods launched its initial public offering of stock this Tuesday (Jan. 28), selling 26 million shares at $20 each ...